Icon (ICLR) Other Non-Current Liabilities (2009 - 2026)
Icon's (ICLR) quarterly Other Non-Current Liabilities came in at $77.7 million in Q2 2026, down 19.97% year-over-year from $97.1 million in Q2 2025, and up 7.38% quarter-over-quarter from $72.3 million in Q1 2026.
Analysis
Icon (ICLR) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Other Non-Current Liabilities for 18 consecutive years, with $77.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 19.97% year-over-year to $77.7 million in Q2 2026; TTM through Jun 2026 was $77.7 million, a 19.97% decrease from a year earlier, with the FY2025 full-year figure at $72.8 million, down 9.4% from the prior year.
- Other Non-Current Liabilities was $77.7 million for Q2 2026 at Icon, up from $72.3 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $99.5 million in Q3 2025 and troughed at $37.8 million in Q4 2022.
- A 5-year average of $58.8 million and a median of $47.3 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities sank 48.53% in 2022 and jumped 100.65% in 2025, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $37.8 million in 2022, then increased by 19.85% to $45.2 million in 2023, then soared by 77.62% to $80.4 million in 2024, then fell by 9.4% to $72.8 million in 2025, then climbed by 6.68% to $77.7 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $77.7 million (Q2 2026), $72.3 million (Q1 2026), and $72.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.67 Mn |
| Mar 31, 2026 | 72.34 Mn |
| Dec 31, 2025 | 72.81 Mn |
| Sep 30, 2025 | 99.49 Mn |
| Jun 30, 2025 | 97.06 Mn |
| Mar 31, 2025 | 85.71 Mn |
| Dec 31, 2024 | 80.36 Mn |
| Sep 30, 2024 | 50.16 Mn |
| Jun 30, 2024 | 48.37 Mn |
| Mar 31, 2024 | 45.99 Mn |
| Dec 31, 2023 | 45.25 Mn |
| Sep 30, 2023 | 41.66 Mn |
| Jun 30, 2023 | 39.44 Mn |
| Mar 31, 2023 | 46.18 Mn |
| Dec 31, 2022 | 37.75 Mn |
| Sep 30, 2022 | 41.89 Mn |
| Jun 30, 2022 | 38.22 Mn |
| Mar 31, 2022 | 38.17 Mn |
| Dec 31, 2021 | 35.92 Mn |
| Sep 30, 2021 | 73.92 Mn |